Sage Therapeutics Inc (SAGE) Return on Assets ROA from the second quarter of 2025 to second quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sage Therapeutics Inc   (NASDAQ: SAGE)


Sage Therapeutics Inc 's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Sage Therapeutics Inc 's ROA in the second quarter of 2025?
Sage Therapeutics Inc recorded a cumulative net loss of $-301 million during 12 months ending in the second quarter of 2025, resulting in a negative return on assets (ROA) of -59.48%.

However, within the Healthcare sector 630 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2025 quarter, so far to 4170, from total ROA ranking in the first quarter of 2025 at 4273.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Total Assets Change -40.58 % -40 % -38.83 % -35.17 % -35.21 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -301 -354 -401 -338 -446
Return On Assets (TTM) -59.48 % -61.41 % -61.27 % -45.66 % -54.19 %
SAGE's Total Ranking # 4170 # 4273 # 4933 # 4191 # 4347
Total Assets (TTM) in million 414 461 539 612 697
Seq. Total Assets Change -10.09 % -14.47 % -11.99 % -12.2 % -9.22 %
Seq. Net Income Change - - - - -

SAGE's 5 Years Annual ROA >> Back to SAGE Management Effectiveness >> Compare SAGE ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 283
Sector # 631
Overall # 4116

Return On Assets Statistics
High Average Low
96.47 %
-37.65 %
-181.56 %
(Dec 31 2012)   (Sep 30 2012)





Financial Statements
Sage Therapeutics Inc 's Assets $ 414 million SAGE's Balance sheet
Sage Therapeutics Inc 's Income $ -50 million Quarterly SAGE's Income Statement
SAGE's Income by Division See SAGE's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020
Y / Y Total Assets Change -38.74 % -34.78 % -25.51 % -15.26 % 97.01 %
Total Assets in million 539 879 1,348 1,810 2,136
Y / Y Net Income Change - - - - -
Net Income in million -401 -541 -533 -458 606
Annual Return On Assets -74.38 % -61.58 % -39.52 % -25.3 % 28.38 %

SAGE's 5 Years Annual ROA >> Back to SAGE Management Effectiveness >> Compare SAGE ROA to its Competitors



More Return On Assets Ratios
SAGE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SAGE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SAGE's Competitors
Subscribers only: Roa for Sage Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for SAGE's Customers

You may also want to know
SAGE's Roi SAGE's Inventory Turnover Ratio SAGE's Growth Rates SAGE's Dividend Comparisons
SAGE's Profitability Ratios SAGE's Asset Turnover Ratio SAGE's Dividend Growth
SAGE's Roe SAGE's Valuation Ratios SAGE's Financial Strength Ratios SAGE's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:06+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.